BioM drives innovation in biotech
Biotechnology has undergone a remarkable transformation in recent years, becoming a dynamic and multifaceted field in which the convergence of areas such as biology, medicine, computer science, and data science plays a central role.
The new tasks of biotechnology lie in increased, interdisciplinary and interactive collaboration. Moreover, the seamless integration of data analysis, cutting-edge digital technologies, such as artificial intelligence and machine learning, is pivotal to staying at the forefront of innovation and ensuring the successful application of biotechnological advancements.
BioM is addressing new trends
BioM is addressing this trend within its new concept AI4Biotech, by which BioM aims to leverage artificial intelligence and advanced (digital) technologies including data science to revolutionise the field and various aspects of nano- and biotechnology in particular for drug development and delivery.
The innovative field of Advanced Therapy Medicinal Products (ATMPs) and the scaling and manufacturing of cell and gene therapeutics will also have a major impact in therapy and cure of diseases. By developing and fostering scientific networks, BioM is contributing to unlock the possibilities of these promising approaches.
To achieve the greatest benefit for society, it is important to carry these trends into all areas and phases of biotechnological developments – and to bring together all players and disciplines. This is what BioM is doing. We bring together all the stakeholders in biotechnology: scientists, founders, entrepreneurs, investors, and politics.
MAxL – for successful start-ups
In addition to our tailored support for founders, we support selected Bavarian pre-seed and early-stage start-up teams from the life sciences and healthtech sectors with the Munich Accelerator Life Sciences & Medicine (MAxL), our unique co-creation start-up incubator. MAxL offers exclusive high-end infrastructure on 900m2, access to a vibrant start-up community and BioM's extensive network. We also offer partnerships with pharma, big biotech, deeptech and other industry players like strategic partners, CROs and investors.
Unlocking the biotech potential
In an increasingly interconnected world, BioM operates from a global perspective. We empower and support Bavarian biotech companies of all stages to broaden their horizons and make a difference through cross-border collaborations on a global and interdisciplinary level. We will continue to drive the future of biotechnology, not only in Bavaria, but throughout Europe and the world. Together, we will continue to unlock the potential of biotechnology.
Prof. Ralf Huss
BioM Biotech Cluster Development GmbH
Am Klopferspitz 19a